| Reporting year |
2022 |
| Provider country/institution - code |
918 |
| Provider country/institution - name |
EU Institutions |
| Provider agency |
European Commission |
| Provider project number |
JAG.598506 |
| TOSSD ID Number |
T2022022578 |
| TOSSD recipient - code |
999 |
| TOSSD recipient - name |
Global |
| Region |
Global |
| Project title |
874807 - AMELIE - H2020-SC1-2019-SINGLE-STAGE-RTD |
| Description |
Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affected individuals and their families. Women with FI arising from childbirth injury may benefit from regenerative medicine using autologous skeletal muscle derived cells (ASMDC) to restore function of damaged sphincter muscle. However, progress is hindered by sub-optimal manufacturing and delivery techniques contributing to inconsistent results. AMELIE proposes |
| External link |
https://amelie-project.eu/ |
| SDG focus |
9.5;3.b;17.3 |
| SDG goal level explanation |
|
| Keywords |
R&D |
| Sector category - code |
120 |
| Sector category - name |
Health |
| Purpose code |
12382 |
| Purpose name |
Research for prevention and control of NCDs |
| ISICcode |
86 |
| ISIC name |
Human health activities |
| ISIC lvl |
Q |
| ISIC description letter lvl |
Human health and social work activities |
| Channel category - code |
11000 |
| Channel category - name |
|
| Other Partners |
|
| Channel - code |
11004 |
| Channel - name |
Other public entities in provider country |
| Channel |
Other public entities in donor country |
| Modality - code |
K02 |
| Modality - name |
RESEARCH AND DEVELOPMENT (R&D) |
| Financial instrument - code |
110 |
| Financial instrument - name |
Standard grant |
| Financing arrangement - code |
|
| Financing arrangement - name |
|
| Framework of collaboration - code |
|
| Framework of collaboration - name |
|
| TOSSD pillar |
2 |
| TOSSD sub-pillar |
2 |
| Amount committed (USD thousand) |
|
| Deflated Amount committed (USD thousand) |
|
| Amount disbursed (USD thousand) |
54.190766642128516 |
| Deflated amount disbursed (USD thousand) |
60.6765511525633 |
| Reflows to the provider (USD thousand) |
|
| Deflated reflows to the provider (USD thousand) |
|
| Amount mobilised (USD thousand) |
|
| Deflated amount mobilised (USD thousand) |
|
| Salary cost (PPPs) |
|
| Concessionality |
1 |
| Maturity (in months) |
|
| Leveraging mechanism |
|
| Origin of the funds mobilised |
|
| Source name |
TOSSD |